![Keyvan Mirsaeedi-Farahani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keyvan Mirsaeedi-Farahani
Directeur/Membre du Conseil chez
Cerebral Therapeutics, Inc.
Fortune : - $ au 30/06/2026
Profil
Keyvan Mirsaeedi-Farahani currently works at Cerebral Therapeutics, Inc., as Director, Adagio Medical Holdings, Inc., as Independent Director from 2024, Perceptive Advisors LLC, as Head of Therapeutics from 2025, and Perceptive Advisors (Private Equity), as Head of Therapeutics from 2016.
Dr. Mirsaeedi-Farahani received his doctorate degree in 2016 from the University of Pennsylvania, undergraduate degree in 2009 from the University of Michigan, and Masters Business Admin degree in 2016 from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Keyvan Mirsaeedi-Farahani
| Sociétés | Poste | Début |
|---|---|---|
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Analyst-Equity | 01/04/2016 |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Private Equity Investor | 01/01/2016 |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases | Directeur/Membre du Conseil | - |
Formation de Keyvan Mirsaeedi-Farahani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Cerebral Therapeutics, Inc.
Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases | Commercial Services |
Choisissez Zonebourse 
